Why the study?
How should dental patients taking new generation oral anticoagulants be managed during invasive procedures?
How should dental patients taking new generation oral anticoagulants be managed during invasive procedures?
Provides proposed clinical guidance for the management of dental patients taking new generation oral anticoagulants, addressing a gap in current national guidelines.
Proposes interim guidance for managing invasive dental procedures in NOAC patients; extends national guidelines by addressing an evidence gap.
Recently, new oral anticoagulants have been introduced as alternatives to warfarin. While national guidelines for treatment of dental patients taking warfarin as an anticoagulant are well-established, no such information is available for these novel therapeutic agents. At present, the local guidance available is contradictory between different health boards/health planning units, and liaison with the medical practitioner managing the individual patient's anticoagulation is imperative if any invasive procedure is proposed. This paper examines the available evidence regarding these drugs and sets out proposals for clinical guidance of dental practitioners treating these patients in primary dental care.
No takes yet. Share an insight, caveat, or question.
Scott et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: